Author:
Xu Mingzhen,Ni Yang,Zhou Ying,He Xiaomeng,Li Huqun,Chen Hui,Li Weiyong
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference15 articles.
1. McCormack PL. Rufinamide: a pharmacoeconomic profile of its use as adjunctive therapy in Lennox–Gastaut syndrome. Pharmacoeconomics. 2012;30:247–56.
2. Glauser T, Kluger G, Sachdeo R, Krauss G, Perdomo C, Arroyo S. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology. 2008;70:1950–8.
3. Palhagen S, Canger R, Henriksen O, Van Parys JA, Riv-iere ME, Karolchyk MA. Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy. Epilepsy Res. 2001;43:115–24.
4. Brodie MJ, Rosenfeld WE, Vazquez B, Sachdeo R, Perdomo C, Mann A, Arroyo S. Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial. Epilepsia. 2009;50:1899–909.
5. Biton V, Krauss G, Vasquez-Santana B, Bibbiani F, Mann A, Perdomo C, Narurkar M. A randomized, double-blind, placebo controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizures. Epilepsia. 2011;52:234–42.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献